This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignees: European Molecular Biology Laboratory, Universitat Heidelberg. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 79 
1 out of 34 
Years Active: 2020
Title: Joe Lewis - Innovator in Cancer Treatment
Introduction
Joe Lewis is a notable inventor based in Dielheim, Germany. He has made significant contributions to the field of medicine, particularly in the area of cancer treatment. His innovative work focuses on the inhibition of fibroblast growth factor 2 (FGF2) secretion by tumor cells.
Latest Patents
Joe Lewis holds a patent for "Inhibitors of the unconventional secretion of fibroblast growth factor 2 (FGF2) by tumor cells and uses thereof." This invention relates to compounds capable of inhibiting the secretion of FGF2 by tumor cells. The applications of this compound are particularly relevant in the prevention and treatment of cancerous or inflammatory diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Joe Lewis has worked with prestigious institutions, including the University of Heidelberg and the European Molecular Biology Laboratory. His research has contributed to advancements in understanding tumor biology and potential therapeutic approaches.
Collaborations
Joe Lewis has collaborated with notable professionals in his field, including Walter Nickel. Their joint efforts have furthered research in cancer treatment and related areas.
Conclusion
Joe Lewis is a dedicated inventor whose work has the potential to impact cancer treatment significantly. His innovative approaches and collaborations highlight the importance of research in developing effective medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile